Mugwagwa T, Karanth S, Nham T, Goyal RK, Esterberg E, Sidhu GS, Yehoshua A, Mokgokong R. Real-world healthcare resource utilization and cost burden of COVID-19 in the us medicare advantage population. Poster to be given at the Academy of Managed Care Pharmacy (AMCP) Nexus 2026; October 26, 2026. San Diego, CA.
Patterson BJ, Meyers J, Karanth S, Esterberg E, Carlson KB, Iqbal S, Kim C. Describing care setting patterns for norovirus gastroenteritis in US adults 2019–2024: a MarketScan database analysis. Poster to be given at the IDWeek 2026; October 24, 2026. Washington, DC.
Xiao Z, Hicks K, Clarke C, Wilker E, Ghaswalla P. Public health and economic impact of mRNA-1345 vaccination on RSV burden in US adults using first-season real-world effectiveness. Poster to be given at the IDWeek 2026; October 21, 2026. Washington, DC.
Xiao L, Hicks K, Clarke C, Wilker E, Ghaswalla P. Estimated impact of increasing RSV vaccination coverage on burden among older adults in the veterans health administration. Poster to be given at the IDWeek 2026; October 21, 2026. Washington, DC.
Hicks K, Xiao Z, Clarke C, Wilker E, Ghaswalla P. Projected public health impact of mRNA-1345 revaccination strategies in the ACIP-recommended US adult population. Poster to be given at the IDWeek 2026; October 21, 2026. Washington, DC.
Iantomasi R, Lopez L, Forns J, Rose Slate S, Findlow J. Global epidemiology of the factor H binding protein in meningococcal serogroup B invasive isolates: a targeted literature review. Front Public Health. 2026 Oct 11;14:1937472. doi: 10.3389/fpubh.2026.1937472
Mugwagwa T, Abramoff BA, Karanth S, Nham T, Goyal RK, Esterberg E, Sidhu GS, Yehoshua A, Mokgokong R. Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis. J Med Econ. 2026 Sep 3. doi: 10.1080/13696998.2026.2725478
Angulo FJ, Zhao G, Yuan W, Yin Z, Yang J, Khan S, Tran D, Gonzalez EN, Sun A, Shen S, Findlow J. Systematic literature review of the Clostridioides Difficile Infection (CDI) disease burden in mainland China. Poster presented at the 9th International C. difficile Symposium; September 8, 2026. Bled, Slovenia.
Angulo FJ, Zhao G, Wu Y, Yin Z, Yang J, Khan S, Tran DW, Gonzalez EN, Sun A, Shen S, Findlow J. Clostridioides difficile Infection (CDI) disease burden (cases, hospitalizations, and deaths) in China: a systematic literature review. Infect Dis Rep. 2026 Jul 3;18(4):67. doi: 10.3390/idr18040067
Visnyei K, Metzner AA, Gelow II RS, Aloysius KK, Pilgrim N, Swygard H, Rab S, Cole KA, Boyle K, Reynolds M, Sherif B, Richardson D, Morris R, Sullivan M, Zografos L. Operational insights for long-acting cabotegravir for HIV-1 pre-exposure prophylaxis: findings from the CAPTIVATE United States healthcare provider survey. Poster presented at the 26th International AIDS Conference; July 26, 2026. Rio de Janeiro, Brazil.
